FDA Approves ZOLADEX — TerSera Therapeutics LLC
# FDA Approves ZOLADEX (Goserelin Acetate) for TerSera Therapeutics TerSera Therapeutics LLC has received FDA approval for ZOLADEX (goserelin acetate), a subcutaneous treatment th…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves ZOLADEX (Goserelin Acetate) for TerSera Therapeutics TerSera Therapeutics LLC has received FDA approval for ZOLADEX (goserelin acetate), a subcutaneous treatment th…
# FDA Approves TERSERA Drug Application TERSERA has received FDA approval for a new drug application (NDA020515), marking a significant entry into the pharmaceutical market as the…
# FDA Approves Baxter Healthcare's Liposomal Doxorubicin Formulation Baxter Healthcare Company received FDA approval for its liposomal doxorubicin hydrochloride formulation on Nov…
# FDA Approves Hospira's Lidocaine Hydrochloride for Epidural Use Hospira, Inc. received FDA approval for its lidocaine hydrochloride epidural formulation, expanding the company's…
Hikma Pharmaceuticals USA Inc. secured FDA approval for Intravenous Acetazolamide Sodium in 1995, expanding its generic portfolio into the IV segment and positioning the company to…
Actavis Pharma, Inc. received FDA approval for its generic glipizide oral tablet, positioning the company to enter the competitive oral anti-diabetic market segment. The clearance …
GlaxoSmithKline announced the FDA approval of oral Atovaquone (Mepron) for the treatment of Pneumocystis pneumonia, a strategic addition expected to broaden the company’s portfolio…
# FDA Approves Hikma Generic Drug Application Hikma Pharmaceuticals has received FDA approval for an abbreviated new drug application (ANDA 074060), positioning the company to exp…
# FDA Approves Sandoz's Apraclonidine for Ophthalmic Use Sandoz Inc. received FDA approval for apraclonidine hydrochloride, an ophthalmic treatment that expands the company's port…
# FDA Approves Baxter Healthcare's Vancomycin Hydrochloride for Intravitreal Injection Baxter Healthcare Corporation received FDA approval for Vancomycin Hydrochloride as an intra…
Hikma Pharmaceuticals USA Inc. secured the approval of a new generic version of LEUCOVORIN CALCIUM, an essential drug indicated for rescue following methotrexate toxicities, potent…
ANI Pharmaceuticals, Inc. announced FDA approval of its oral Valproic Acid generic (ANDA073178), a development that further diversifies the company's product portfolio and strength…
Actavis Pharma has confirmed the continued availability of the approved brand and generically equivalent Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate (NDA020232), a 3…
# FDA Approves Organon's PROSCAR (Finasteride) for Oral Use Organon LLC received FDA approval for PROSCAR (finasteride), an oral medication that is expected to capture significant…
# FDA Approval Newswire Mylan Pharmaceuticals Inc. received FDA approval for its oral methotrexate sodium formulation (ANDA081235), expanding the company's oncology and immunology…
Actavis Pharma, Inc. has received approval for its generic version of minocycline hydrochloride (ANDA063181), a timely move that increases competition and may limit pricing pressur…
Aiping Pharm Inc secured FDA approval via this Abbreviated New Drug Application, a regulatory milestone that establishes the pathway for market distribution and generic competition…
KING PHARMS LLC has received FDA regulatory approval for NDA019901, establishing formal clearance for a new pharmaceutical entry. This development carries significant market implic…
# FDA Approves Teva Pharmaceuticals' Generic Methotrexate Oral Formulation Teva Pharmaceuticals USA, Inc. received FDA approval for its generic methotrexate sodium oral formulatio…
ALVOGEN has received FDA approval for its Abbreviated New Drug Application (ANDA063067), reinforcing the company's competitive positioning in the generic sector as the industry fac…